Edelman and Kekst and Company are advising Irish pharmaceutical maker Mallinckrodt's $1.3B acquisition of Cadence Pharmaceuticals.
Kekst vice chair Jeff Taufield supports Mallinckrodt's U.S. in-house team, which is based in St. Louis and led by SVP of communications and public affairs Meredith Fischer and VP of IR John Moten.
Edelman guides PR for San Diego-based Cadence, a biopharma company that makes drugs used in a hospital setting.
Cadence's OFIRMEV acetaminophen injection chalked up net revenues of $110.5M in 2013, more than doubling the prior year's sales.
The $14-per-share tender offer announced Feb. 11 is a 32% premium on Cadence shares.
The deal is expected to close next month.
Lo Isidro, senior director at Real Chemistry with more than a decade of strategic communications and PA experience, has joined Narrative Strategies.
Nelson Fernandez, former North American chair of APCO Worldwide and managing director of Burson-Marsteller, has joined Volunteers in Medicine Berkshires as director of communications and PA.
Lilit Bargar, who was most recently an EVP in the healthcare practice at Weber Shandwick, comes on board at GCI Health as EVP, corporate practice lead.
Five ways that successful thought leaders are made.
Have a comment? Send it to 
No comments have been submitted for this story yet.